HomeNewsBusinessReal EstateAjmera Realty to invest around Rs 1,000 crore in four projects despite COVID-19

Ajmera Realty to invest around Rs 1,000 crore in four projects despite COVID-19

The projects in Mumbai, Bengaluru and Pune would be spread across 15 lakh sq ft. Ajmera Realty also plans to complete four projects in London this fiscal.

May 28, 2021 / 11:02 IST
Story continues below Advertisement
Dhaval Ajmera, director, Ajmera Realty & Infra India Ltd
Dhaval Ajmera, director, Ajmera Realty & Infra India Ltd

Dhaval Ajmera, director, Ajmera Realty & Infra India Ltd, is an optimist and believes the long-term real-estate story remains intact. He is looking forward to launch four projects, spread across 15 lakh sq ft in Mumbai, Bengaluru and Pune this year.

The 40-year-old Ajmera, who is into adventure sports, and has completed four full marathons, is a firm believer in paring debt and hopes to reduce it by 20-30 percent more this fiscal.

Story continues below Advertisement

The company recently decided to exit from its project in Bahrain.

In an interview with Moneycontrol, Ajmera talks about the impact of the second COVID wave on residential and the commercial segments. Edited excerpts:

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show